The letrozole breast cancer trial: Clinical implications and remaining questions

被引:27
作者
Chen, WY
Manson, JE
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Dana Farber Canc Inst, Div Med Oncol, Boston, MA USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.whi.2003.12.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:7 / 10
页数:4
相关论文
共 19 条
[1]   Bone loss and bone size after menopause [J].
Ahlborg, HG ;
Johnell, O ;
Turner, CH ;
Rannevik, G ;
Karlsson, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :327-334
[2]  
Baum M, 2003, Cancer, V98, P1802
[3]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[4]   Letrozole after tamoxifen for breast cancer - What is the price of success? [J].
Bryant, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19) :1855-1857
[5]   Beyond tamoxifen - Extending endocrine treatment for early-stage breast cancer [J].
Burstein, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19) :1857-1859
[6]   Overview of the main outcomes in breast-cancer prevention trials [J].
Cuzick, J ;
Powles, T ;
Veronesi, U ;
Forbes, J ;
Edwards, R ;
Ashley, S ;
Boyle, P .
LANCET, 2003, 361 (9354) :296-300
[7]  
Dewar J., 2000, Breast Cancer Research and Treatment, V64, P51
[8]   Effect of letrozole on the lipid profile in postmenopausal women with breast cancer [J].
Elisaf, MS ;
Bairaktari, ET ;
Nicolaides, C ;
Kakaidi, B ;
Tzallas, CS ;
Katsaraki, A ;
Pavlidis, NA .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) :1510-1513
[9]  
Ellis M, 2000, DIS BREAST
[10]  
FOMANDER T, 1989, LANCET, V1, P117